The impact of alcohol sale restriction on alcoholism and drug addiction in the Chechen republic

2011 ◽  
Vol 26 (S2) ◽  
pp. 20-20
Author(s):  
M. Dalsaev ◽  
R. Dalsaeva
Keyword(s):  
Drug Treatment ◽  
Drug Addiction ◽  
Drug Law ◽  
The Impact

The restriction on alcohol sale in the Chechen republic was introduced in 2009.During that period a stable trend of alcoholism growth was registered, which in the same time was outrunning a growth of drug addiction in the Chechen republic.Analysis on drug addiction and alcoholism for the period from 2008 through 2010 brought light to reducing of alcoholism in comparing to 2008 for 91%. This is against the background of drug addiction growth for 28%.The reducing number of intoxicated vehicle drivers was also noted during that period.The total number of crimes violating drug law has changed slightly, but the proportion of patients admitted for inpatient drug treatment increased.Relying on analysis made during our research a conclusion on effectiveness of alcohol sale restriction on alcoholism and danger of complete ban of alcohol sale was made. It not only can’t solve the problem but may negatively affect the growth of drug addiction in society.

scholarly journals POS0291 THE IMPACT OF DRUG INDUCED AND OTHER RHEUMATIC MUSCULOSKELETAL DISORDERS (MD) ON THE QUALITY OF LIFE (QOL) OF CANCER PATIENTS RECEIVED ANTICANCER DRUG TREATMENT

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 371.1-371
Author(s):  
A. Koltakova ◽  
A. Lila ◽  
L. P. Ananyeva ◽  
A. Fedenko
Keyword(s):  
Drug Treatment ◽  
Cancer Patients ◽  
Anticancer Drug ◽  
Physical Functioning ◽  
Role Functioning ◽  
Drug Induced ◽  
Significant Difference ◽  
Eortc Qlq C30 ◽  
Eortc Qlq ◽  
The Impact

Background:Pts with cancer may have MD that can be caused by neoplastic/paraneoplastic disease, rheumatic diseases or be induced by anticancer drug treatment. There is no data about MD influence on the QoL of cancer patients. The EORTC QoL questionnaire (QLQ)-C30 is a valid questionnaire designed to assess different aspects (Global health (GH), Functional (FS) and symptoms (SS) scales) that define the QoL of cancer patients [1].Objectives:The objective of the study was to assess the impact of drug induced and other types of MD on the QoL of cancer patients that received anticancer drug treatment by using of EORTC QLQ-C30 v3.0.Methods:The sampling of 123 pts (M/F – 40/83; mean age 54.4±12.8) with breast (32,5%), gastrointestinal (17%), ovary (8%), lung (7%) and other cancer was observed by rheumatologist in the oncology outpatient clinic. All pts received anticancer drug treatment: chemotherapy (104 pts), target therapy (16 pts) checkpoint-inhibitors (14 pts), hormone therapy (13 pts) in different combinations. 102(82.9%) of 123pts had MD include arthritis (12 pts), synovitis (5 pts), arthralgia (66 pts), periarthritis (34 pts), osteodynia (13 pts). There were 58 pts (group 1; M/F – 14/44; mean age 52.5±12.2) with anticancer drug treatment induced MD and 44 pts (group 2; M/F – 16/27; mean age 57.6±13.5) with other type of MD include 26 pts with skeletal metastasis. The were 21 pts (group 3; M/F – 10/11; mean age 52.9±11.1) without MD. All pts fulfilled EORTC QLQ-C30 v3.0 (tab.1).Table 1.The median [Q1;Q3] of results of GH, SS and SS of EORTC QLQ-C30ScaleSubscaleGroup1Group2Group3GH58.3[50;58]58.3[41.7;83.3]50[50;66.7]FS*Physical functioning73.3[60;86.7]73.3[66.7;86.7]86.7[80;93]Role functioning66.7[66.7;100]83.3[50;100]100[83;100]Emotional functioning83.3[66.7;100]75[66.7;91.7]91.6[83.3;100]Social functioning83.3[66.7;100]83.3[50;100]100[83.3;100]SS*Pain33.3[0;50]16.7[0;33.3]0[0;16.7]*There are only the scores that had got a statistical difference between the groups.Kruskal-Wallis H and post-hoc (Dwass-Steel-Critchlow-Fligner (DSCF) pairwise comparisons) tests for data analysis were performed.Results:A Kruskal-Wallis H test has shown a statistically significant difference in physical (χ2(2)=7.54; p=0.023), role (χ2(2)=9.87; p=0.007), emotion (χ2(2)=7.69; p=0.021) functioning and pain (χ2(2)=8.44; p=0.015) scores between the different groups. A post-hoc test with DSCF pairwise comparisons of median has shown a statistically significant difference between 1 and 3 groups (W=3.904; p=0.016) for physical functioning, between 2 and 3 groups (W=3.35; p=0.004) for role functioning, between 2 and 3 groups (W=4.03; p=0.012) for emotional functioning, between 1 and 3 groups (W=-3.97; p=0.014) for pain scale.Conclusion:The study has shown that MD associated with anticancer drug treatment adversely affected the QoL of cancer patients received anticancer drug treatment by reducing a physical functioning and by increasing pain scores. Presence of other types of MD adversely affect the QoL by reducing emotional and role functioning.References:[1]Aaronson NK,et al.The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst.1993;85(5):365-376. doi:10.1093/jnci/85.5.365Disclosure of Interests:None declared

Injecting risk behaviour among recently released prisoners in Edinburgh: The impact of in-prison and community drug treatment services

2001 ◽  
Vol 6 (1) ◽  
pp. 19-28 ◽  
Author(s):  
David Shewan ◽  
Margaret Reid ◽  
Sandy MacPherson ◽  
John B. Davies ◽  
Judy Greenwood
Keyword(s):  
Drug Treatment ◽  
Risk Behaviour ◽  
Treatment Services ◽  
The Impact

scholarly journals Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment

2020 ◽  
Vol 18 (Suppl) ◽  
Author(s):  
Danilo Villagelin ◽  
Roberto Bernardo Santos ◽  
João Hamilton Romaldini
Keyword(s):  
Drug Treatment ◽  
Remission Rate ◽  
Antithyroid Drug ◽  
Antithyroid Drugs ◽  
Graves Disease ◽  
Remission Rates ◽  
Thyrotropin Receptor Antibodies ◽  
Antithyroid Drug Treatment ◽  
The Impact ◽  
Receptor Antibodies

Context: Graves’ disease is an autoimmune disease caused by thyrotropin receptor antibodies (TRAb). These antibodies can be measured and used for the diagnosis, prediction of remission, and risk of Graves’ orbitopathy development. There are three treatments for Graves’ disease that have remained unchanged for the last 75 years: Antithyroid drugs, radioiodine, and surgery. Antithyroid drugs are the first treatment option worldwide and are usually used for 12 - 18 months. Recent reports suggest the use of antithyroid drugs for more than 18 months with better outcomes. This review focuses on two aspects of treatment with antithyroid drugs: The impact of using antithyroid drugs for more than 12 - 18 months on remission rates and the trend of TRAb during prolonged antithyroid drug treatment. Evidence Acquisition: A review was performed in Medline on the published work regarding the duration of ATD treatment and remission of Graves' disease and also ATD treatment and TRAb status during the 1990 - 2019 period. Results: Remission rates are variable (30% - 80%), and many clinical and genetic factors serve as predictors. The long-term use of antithyroid drugs appears to increase remission rates. TRAb values usually decline during ATD treatment, but the trend could occur in two ways: Becoming negative or showing a fluctuating pattern. However, approximately 10% of the patients will remain TRAb-positive after five years of treatment with antithyroid drugs. Conclusions: Antithyroid drugs can be used for long periods with an increase in remission rates, and a gradual decrease in TRAb levels, with the disappearance of TRAb in 90% of the patients after 60 months.

scholarly journals Special features of designing a correction program for adolescents who have signs of psychosomatic disorders

2020 ◽  
pp. 19-38
Author(s):  
Iryna ROZINA
Keyword(s):  
Drug Addiction ◽  
Healthy Children ◽  
Negative Consequences ◽  
Psychosomatic Disorders ◽  
Effective Response ◽  
Neurotic Disorders ◽  
Correction Program ◽  
The Subject ◽  
The Impact

The relevance of the research is related to the need for studying the character of psychosomatic disorders in adolescence, which is insufficiently investigated and requires more in-depth research, in particular designing a comprehensive program that includes a system of training exercises to overcome psychosomatic disorders. The problem of studying psychosomatic relationships is one of the most difficult problems of modern psychology and medicine, despite the fact that the close connection between mental and somatic has been studied for several centuries. Mental trauma is a leading cause of neuroses formation and progress, its pathogenic significance is determined by the complex interaction with many other factors being a result of an individual’s life, formation of his body and personality, especially in adolescence. The subject of the research is to study special features of psychosomatic disorders, as well as to design a program for adolescents with signs of neurotic disorders. The subject matter of the research is the peculiarities of psychosomatic disorders manifestation and neurotic signs in adolescence. The article presents a theoretical analysis of modern approaches in psychology to the study of psychosomatic disorders peculiarities, their classification, considering the signs of neurotic disorders in adolescence. The work analyzes age characteristics of psychosomatic disorders in adolescence. Modern adolescents are exposed to various stressors, to the impact of audiovisual information, school overload, extra classes, exams, and a special problem that is a change in quality of life and prevalence of alcoholism, smoking, drug addiction, especially drug addiction among adolescents. The complex of these factors has negative consequences both on a psychological and physical level. Most authors who study the causes of psychosomatic illnesses recognize the important role of parents in the development of mentally and physically healthy children. Many studies highlight the role of early mother-child relationships in the formation of psychosomatic pathology. Various violations of this relationship usually lead to abnormalities in a child’s development. (M. Mahler, E. T. Eidemiller, Yustitskis, D. Winnicott, M. Klein). The results of an empirical study aimed at identifying signs of psychosomatic disorders are considered. The following methods were used: observation, questionnaires, and such methods as diagnosis of neurotic disorders in adolescence (DND), diagnosis of the level of school anxiety by Phillips, “Non-existent animal” by M.Z. Drukarevich. The peculiarities of designing and testing the correction program, which is aimed at reducing the signs of neurotic manifestations in adolescence, are revealed. Objectives of the correction program are: searching for interaction of adolescents with society, finding and testing skills of effective response to external stimuli; increasing the level of self-esteem; removal of emotional tension; reducing anxiety. The results confirm the possibility of reducing the signs of neurotic manifestations of adolescents and help to delay or completely stop a possible personality disorder.

Patient perspectives

2010 ◽  
pp. 181-187
Author(s):  
S. Jos Closs
Keyword(s):  
Quality Of Life ◽  
Neuropathic Pain ◽  
Suicidal Ideation ◽  
Side Effects ◽  
Focus Group ◽  
Drug Treatment ◽  
Sleep Disturbance ◽  
Focus Group Research ◽  
The Impact

The impact of neuropathic pain on quality of life has been under-researched and poorly understood though survey and focus group research is helping to gain better insights into what patients suffer Neuropathic pain can result in significant sleep disturbance, fatigue, and low mood (that sometimes leads to suicidal ideation), and side-effects from drug treatment are common...

scholarly journals Drug Treatment Participation and Retention Rates among Former Recipients of Supplemental Security Income for Drug Addiction and Alcoholism

2003 ◽  
Vol 30 (1-2) ◽  
pp. 335-364 ◽  
Author(s):  
James A. Swartz ◽  
Kevin Campbell ◽  
Jim Baumohl ◽  
Peggy Tonkin
Keyword(s):  
Drug Treatment ◽  
Drug Addiction ◽  
Total Sample ◽  
Supplemental Security Income ◽  
Treatment Retention ◽  
Retention Rates ◽  
Federal Legislation ◽  
Survival Analyses ◽  
Formal Treatment ◽  
Treatment Participation

This study examined drug treatment participation and retention rates for a multisite sample of 1,586 former recipients of Supplemental Security Income (SSI) for drug addiction and alcoholism (DA&A). Fewer than half of the sample were complying with the DA&A program treatment mandate at the time the program was terminated by federal legislation in January 1997. For all forms of treatment, both participation and retention rates declined steadily thereafter until fewer than 10% of the total sample reported being in a formal treatment two years after termination of the mandate. Survival analyses comparing treatment retention rates for DA&A beneficiaries with non-DA&A SSI beneficiaries revealed that most of the decline in treatment retention could be attributed to ending the mandate. The findings suggest that although the mandate was often not well enforced, it did bring into drug treatment many individuals who would not otherwise have participated.

Cocaine use during pregnancy and low birth weight: The impact of prenatal care and drug treatment

1995 ◽  
Vol 19 (4) ◽  
pp. 293-300 ◽  
Author(s):  
Cynthia Chazotte ◽  
Joan Youchah ◽  
Margaret Comerford Freda
Keyword(s):  
Birth Weight ◽  
Prenatal Care ◽  
Low Birth Weight ◽  
Drug Treatment ◽  
Cocaine Use ◽  
The Impact

scholarly journals Twisting Arms Or a Helping Hand?: Assessing the Impact of 'Coerced' and Comparable 'Voluntary' Drug Treatment Options

2006 ◽  
Vol 47 (3) ◽  
pp. 470-490 ◽  
Author(s):  
T. McSweeney ◽  
A. Stevens ◽  
N. Hunt ◽  
P. J. Turnbull
Keyword(s):  
Drug Treatment ◽  
Treatment Options ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document